Symptoms after COVID-19 Infection in Individuals with Multiple Sclerosis in Poland

Symptoms after COVID-19 Infection in Individuals with Multiple Sclerosis in Poland

(1) Background: To report and analyze the presence of residual symptoms after SARS-CoV-2 infection among Polish patients with multiple sclerosis (MS) treated with different disease-modifying therapies (DMTs). (2) Methods: The study included 426 individuals with MS treated with DMTs and confirmed SAR...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Agata Czarnowska, Katarzyna Kapica-Topczewska, Olga Zajkowska, Monika Adamczyk-Sowa, Katarzyna Kubicka-Bączyk, Natalia Niedziela, Paweł Warmus, Alicja Kalinowska-Łyszczarz, Karolina Kania, Agnieszka Słowik, Marcin Wnuk, Monika Marona, Klaudia Nowak, Halina Bartosik-Psujek, Beata Lech, Adam Perenc, Małgorzata Popiel, Marta Kucharska-Lipowska, Monika Chorąży, Joanna Tarasiuk, Anna Mirończuk, Jan Kochanowicz, Anetta Lasek-Bal, Przemysław Puz, Katarzyna Maciejowska, Sławomir Wawrzyniak, Anna Niezgodzińska-Maciejek, Anna Pokryszko-Dragan, Ewa Gruszka, Sławomir Budrewicz, Marta Białek, Jacek Zwiernik, Anna Michałowska, Krzysztof Nosek, Beata Zwiernik, Bożena Lewańczyk, Waldemar Brola, Alina Kułakowska
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
multiple sclerosis
COVID-19
SARS-CoV-2
disease modifying therapies
residual symptoms
Medicine
R
Accès en ligne:https://doaj.org/article/812471485cba43638a8b703fa750442d
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/812471485cba43638a8b703fa750442d

Documents similaires